Phase 3

Efficacy and Safety of LYR-210 for the Treatment of Chronic Rhinosinusitis in Adults (ENLIGHTEN 2)

Sponsor:

Lyra Therapeutics

Code:

NCT05295459

Conditions

Chronic Sinusitis

Chronic Rhinosinusitis (Diagnosis)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

LYR-210

Sham procedure control

Background therapy

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information